本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

64.74
+1.261.98%
盤後64.740.00000.00%19:30 EDT
成交量:138.47萬
成交額:8,950.94萬
市值:61.02億
市盈率:-135.88
高:65.86
開:64.51
低:63.84
收:63.48
52周最高:68.73
52周最低:22.06
股本:9,426.11萬
流通股本:9,276.71萬
量比:0.87
換手率:1.49%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:248.86
市盈率(LYR):-226.09

資料載入中...

2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

重要事件披露

Form 8-K - Current report
2024/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/06/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/24

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities